About Keting Chu
Form D filings for Bluejay Therapeutics from 2021 to 2024 list Keting Chu as chief executive officer and director.
Keting Chu first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Keting Chu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Keting Chu works with at each company, as listed on that company's latest Form D.
Bluejay Therapeutics, Inc. · Form D, May 10, 2024
DE
Dan Estes
Director
PK
Pascal Krotee
Director
JL
Jianqing Li
Director
AL
Alon Lazarus
Director
DY
Dajun Yang
Director